Company Description
Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Europe, the Middle East, Africa, the Asia Pacific, and internationally.
The company provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; Ekso Indego Therapy, an adjustable and lower-limb powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; Ekso Nomad, a power knee ankle foot orthosis; and Ekso EVO, a wearable upper body exoskeleton that elevates and supports a worker's arms to assist with tasks from chest height to overhead.
It also offers EksoCare offering an extended warranty and premium service options, repairs and maintenance services, and training programs.
Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.
| Country | United States |
| Founded | 2005 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 66 |
| CEO | Scott Davis |
Contact Details
Address: 101 Glacier Point, Suite A San Rafael, California 94901 United States | |
| Phone | 510 984 1761 |
| Website | eksobionics.com |
Stock Details
| Ticker Symbol | EKSO |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001549084 |
| CUSIP Number | 282644400 |
| ISIN Number | US2826444000 |
| SIC Code | 3569 |
Key Executives
| Name | Position |
|---|---|
| Scott G. Davis | Chief Executive Officer and Director |
| Jerome Wong | Chief Financial Officer and Corporate Secretary |
| Jason C. Jones | Chief Operating Officer |
| Lisa Bentley | Head of Marketing |
| Ann Cookson | Human Resources Director |
| Foon Lim Chwee | President of APAC |
| Stephan Aderhold | Senior Vice President and GM of EMEA |
| Katherine Strausser | Principal Controls Engineer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 28, 2025 | 10-Q | Quarterly Report |
| Jul 28, 2025 | 8-K | Current Report |
| May 29, 2025 | S-8 | Securities to be offered to employees in employee benefit plans |
| May 21, 2025 | 8-K | Current Report |
| May 20, 2025 | 8-K | Current Report |
| May 15, 2025 | SCHEDULE 13G/A | Filing |
| May 5, 2025 | 10-Q | Quarterly Report |
| May 5, 2025 | 8-K | Current Report |
| Apr 18, 2025 | 11-K | Annual report of employee stock purchase, savings and similar plans |
| Apr 17, 2025 | EFFECT | Notice of Effectiveness |